Advertisement

Nanomedicine and Nanoemulsion in Increasing the Availability of Antibiotics

  • Xinli LiuEmail author
  • Wei Li
Chapter

Abstract

There is a pressing need for the discovery of new antimicrobials and novel, antimicrobial targeting strategies. Many antimicrobials in preclinical and clinical development have poor aqueous solubility, which limits their clinical development and usage due to the low bioavailability. Enhancement of bioavailability in antimicrobials is, therefore, of great importance for achieving therapeutically effective doses and desired concentrations of drugs for the treatment of infectious diseases. Nanomedicine has enormous potential for the prevention and treatment of infectious diseases. Nanoemulsion is one type of clinically useful formulation that can provide a substantial advantage over the conventional formulation of antibiotics since the antibacterial activity of antibiotics can be significantly enhanced by dispensing them in nanoparticulate dosage form. This sustained delivery system can help to deliver antibiotics with poor solubility and pharmaceutical properties, improve the systemic or local drug bioavailability and enhance the therapeutic efficacy.

Keywords

Nanomedicine Emulsions Nanoemulsions Antibiotics delivery Antibiotics bioavailability 

References

  1. Ahmed, M., Ramadan, W., Rambhu, D., & Shakeel, F. (2008). Potential of nanoemulsions for intravenous delivery of rifampicin. Die Pharmazie, 63, 806–811.PubMedGoogle Scholar
  2. Baspinar, Y., & Borchert, H. H. (2012). Penetration and release studies of positively and negatively charged nanoemulsions–is there a benefit of the positive charge? International Journal of Pharmaceutics, 430, 247–252.  https://doi.org/10.1016/j.ijpharm.2012.03.040.CrossRefPubMedGoogle Scholar
  3. Borges, V. R., Simon, A., Sena, A. R., Cabral, L. M., & de Sousa, V. P. (2013). Nanoemulsion containing dapsone for topical administration: A study of in vitro release and epidermal permeation. International Journal of Nanomedicine, 8, 535–544.  https://doi.org/10.2147/ijn.s39383.CrossRefPubMedGoogle Scholar
  4. Burnham, C. D., Leeds, J., Nordmann, P., O’Grady, J., & Patel, J. (2017). Diagnosing antimicrobial resistance. Nature Reviews Microbiology, 15, 697–703.  https://doi.org/10.1038/nrmicro.2017.103.CrossRefPubMedGoogle Scholar
  5. Chang, Y., McLandsborough, L., & McClements, D. J. (2013). Physicochemical properties and antimicrobial efficacy of carvacrol nanoemulsions formed by spontaneous emulsification. Journal of Agricultural and Food Chemistry, 61, 8906–8913.  https://doi.org/10.1021/jf402147p.CrossRefPubMedGoogle Scholar
  6. Chhibber, T., Wadhwa, S., Chadha, P., Sharma, G., & Katare, O. P. (2015). Phospholipid structured microemulsion as effective carrier system with potential in methicillin sensitive Staphylococcus aureus (MSSA) involved burn wound infection. Journal of Drug Targeting, 23, 943–952.  https://doi.org/10.3109/1061186x.2015.1048518.CrossRefPubMedGoogle Scholar
  7. da Silva Gundel, S., et al. (2018). Nanoemulsions containing Cymbopogon flexuosus essential oil: Development, characterization, stability study and evaluation of antimicrobial and antibiofilm activities. Microbial Pathogenesis, 118, 268–276.  https://doi.org/10.1016/j.micpath.2018.03.043.CrossRefPubMedGoogle Scholar
  8. Davies, J. (2006). Where have all the antibiotics gone? Canadian Journal of Infectious Diseases and Medical Microbiology, 17, 287–290.CrossRefGoogle Scholar
  9. Floyd, A. G. (1999). Top ten considerations in the development of parenteral emulsions. Pharmaceutical Science & Technology Today, 2, 134–143.CrossRefGoogle Scholar
  10. Franklyne, J. S., Mukherjee, A., & Chandrasekaran, N. (2016). Essential oil micro- and nanoemulsions: Promising roles in antimicrobial therapy targeting human pathogens. Letters in Applied Microbiology, 63, 322–334.  https://doi.org/10.1111/lam.12631.CrossRefPubMedGoogle Scholar
  11. Hak, S., et al. (2012). The effect of nanoparticle polyethylene glycol surface density on ligand-directed tumor targeting studied in vivo by dual modality imaging. ACS Nano, 6, 5648–5658.  https://doi.org/10.1021/nn301630n.CrossRefPubMedPubMedCentralGoogle Scholar
  12. Hamouda, T., et al. (1999). A novel surfactant nanoemulsion with broad-spectrum sporicidal activity against Bacillus species. The Journal of Infectious Diseases, 180, 1939–1949.  https://doi.org/10.1086/315124.CrossRefPubMedGoogle Scholar
  13. Hamouda, T., Myc, A., Donovan, B., Shih, A. Y., Reuter, J. D., & Baker, J. R., Jr. (2001). A novel surfactant nanoemulsion with a unique non-irritant topical antimicrobial activity against bacteria, enveloped viruses and fungi. Microbiological Research, 156, 1–7.CrossRefGoogle Scholar
  14. Havel, R. J., Kane, J. P., & Kashyap, M. L. (1973). Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man. The Journal of Clinical Investigation, 52, 32–38.  https://doi.org/10.1172/jci107171.CrossRefPubMedPubMedCentralGoogle Scholar
  15. Hemmila, M. R., et al. (2010). Topical nanoemulsion therapy reduces bacterial wound infection and inflammation after burn injury. Surgery, 148, 499–509.  https://doi.org/10.1016/j.surg.2010.01.001.CrossRefPubMedPubMedCentralGoogle Scholar
  16. Hormann, K., & Zimmer, A. (2016). Drug delivery and drug targeting with parenteral lipid nanoemulsions – A review. Journal of Controlled Release: Official Journal of the Controlled Release Society, 223, 85–98.  https://doi.org/10.1016/j.jconrel.2015.12.016.CrossRefGoogle Scholar
  17. Huh, A. J., & Kwon, Y. J. (2011). “Nanoantibiotics”: A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. Journal of Controlled Release: Official Journal of the Controlled Release Society, 156, 128–145.  https://doi.org/10.1016/j.jconrel.2011.07.002.CrossRefGoogle Scholar
  18. Kanke, M., Simmons, G. H., Weiss, D. L., Bivins, B. A., & DeLuca, P. P. (1980). Clearance of 141Ce-labeled microspheres from blood and distribution in specific organs following intravenous and intraarterial administration in beagle dogs. Journal of Pharmaceutical Sciences, 67, 755–762.CrossRefGoogle Scholar
  19. Liang, R., Xu, S., Shoemaker, C. F., Li, Y., Zhong, F., & Huang, Q. (2012). Physical and antimicrobial properties of peppermint oil nanoemulsions. Journal of Agricultural and Food Chemistry, 60, 7548–7555.  https://doi.org/10.1021/jf301129k.CrossRefPubMedGoogle Scholar
  20. MacFie, J. (1999). The development of fat emulsions. Nutrition (Burbank, Los Angeles County, Calif), 15(641), 643–645.Google Scholar
  21. Myc, A., Vanhecke, T., Landers, J. J., Hamouda, T., & Baker, J. R., Jr. (2002). The fungicidal activity of novel nanoemulsion (X8W60PC) against clinically important yeast and filamentous fungi. Mycopathologia, 155, 195–201.CrossRefGoogle Scholar
  22. Nikonenko, B., Reddy, V. M., Bogatcheva, E., Protopopova, M., Einck, L., & Nacy, C. A. (2014). Therapeutic efficacy of SQ641-NE against mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy, 58, 587–589.  https://doi.org/10.1128/aac.01254-13.CrossRefPubMedPubMedCentralGoogle Scholar
  23. Orizondo, R. A., Fabiilli, M. L., Morales, M. A., & Cook, K. E. (2016). Effects of emulsion composition on pulmonary tobramycin delivery during antibacterial perfluorocarbon ventilation. Journal of Aerosol Medicine and Pulmonary Drug Delivery, 29, 251–259.  https://doi.org/10.1089/jamp.2015.1235.CrossRefPubMedPubMedCentralGoogle Scholar
  24. Pelgrift, R. Y., & Friedman, A. J. (2013). Nanotechnology as a therapeutic tool to combat microbial resistance. Advanced Drug Delivery Reviews, 65, 1803–1815.  https://doi.org/10.1016/j.addr.2013.07.011.CrossRefPubMedGoogle Scholar
  25. Prankerd, R. J., & Stella, V. J. (1990). The use of oil-in-water emulsions as a vehicle for parenteral drug administration. Journal of Parenteral Science and Technology: A Publication of the Parenteral Drug Association, 44, 139–149.Google Scholar
  26. Qhattal, H. S., Wang, S., Salihima, T., Srivastava, S. K., & Liu, X. (2011). Nanoemulsions of cancer chemopreventive agent benzyl isothiocyanate display enhanced solubility, dissolution, and permeability. Journal of Agricultural and Food Chemistry, 59, 12396–12404.  https://doi.org/10.1021/jf202612b.CrossRefPubMedGoogle Scholar
  27. Rai, V. K., Mishra, N., Yadav, K. S., & Yadav, N. P. (2018). Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: Formulation development, stability issues, basic considerations and applications. Journal of Controlled Release: Official Journal of the Controlled Release Society, 270, 203–225.  https://doi.org/10.1016/j.jconrel.2017.11.049.CrossRefGoogle Scholar
  28. Santos-Magalhaes, N. S., Pontes, A., Pereira, V. M., & Caetano, M. N. (2000). Colloidal carriers for benzathine penicillin G: Nanoemulsions and nanocapsules. International Journal of Pharmaceutics, 208, 71–80.CrossRefGoogle Scholar
  29. Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017). Cancer nanomedicine: Progress, challenges and opportunities. Nature Reviews Cancer, 17, 20–37.  https://doi.org/10.1038/nrc.2016.108.CrossRefPubMedGoogle Scholar
  30. Singh, Y., Meher, J. G., Raval, K., Khan, F. A., Chaurasia, M., Jain, N. K., & Chourasia, M. K. (2017). Nanoemulsion: Concepts, development and applications in drug delivery. Journal of Controlled Release: Official Journal of the Controlled Release Society, 252, 28–49.  https://doi.org/10.1016/j.jconrel.2017.03.008.CrossRefGoogle Scholar
  31. Tonin, F. S., Steimbach, L. M., Borba, H. H., Sanches, A. C., Wiens, A., Pontarolo, R., & Fernandez-Llimos, F. (2017). Efficacy and safety of amphotericin B formulations: A network meta-analysis and a multicriteria decision analysis. The Journal of Pharmacy and Pharmacology, 69, 1672–1683.  https://doi.org/10.1111/jphp.12802.CrossRefPubMedGoogle Scholar
  32. Torchilin, V. P. (2014). Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nature Reviews Drug Discovery, 13, 813–827.  https://doi.org/10.1038/nrd4333.CrossRefPubMedPubMedCentralGoogle Scholar
  33. Ustundag-Okur, N., Gokce, E. H., Egrilmez, S., Ozer, O., & Ertan, G. (2014). Novel ofloxacin-loaded microemulsion formulations for ocular delivery. Journal of Ocular Pharmacology and Therapeutics: The Official Journal of the Association for Ocular Pharmacology and Therapeutics, 30, 319–332.  https://doi.org/10.1089/jop.2013.0114.CrossRefGoogle Scholar
  34. Webster, T. J. (2006). Nanomedicine: what’s in a definition? International Journal of Nanomedicine, 1, 115–116.CrossRefGoogle Scholar
  35. Weissig, V., & Guzman-Villanueva, D. (2015). Nanopharmaceuticals (part 2): Products in the pipeline. International Journal of Nanomedicine, 10, 1245–1257.  https://doi.org/10.2147/ijn.s65526.CrossRefPubMedPubMedCentralGoogle Scholar
  36. Weissig, V., Pettinger, T. K., & Murdock, N. (2014). Nanopharmaceuticals (part 1): Products on the market. International Journal of Nanomedicine, 9, 4357–4373.  https://doi.org/10.2147/ijn.s46900.CrossRefPubMedPubMedCentralGoogle Scholar
  37. Wretlind, A. (1999). Development of fat emulsions. 1981. Nutrition (Burbank, Los Angeles County, Calif), 15, 642.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Department of Pharmacological and Pharmaceutical SciencesUniversity of HoustonHoustonUSA
  2. 2.Department of Chemical EngineeringTexas Tech UniversityLubbockUSA

Personalised recommendations